Chris Tovey

2021

In 2021, Chris Tovey earned a total compensation of $4.2M as Executive Vice President and Chief Operating Officer and Managing Director, Europe and International at Jazz Pharmaceuticals.

Compensation breakdown

Bonus$297,567
Non-Equity Incentive Plan$211,782
Salary$366,576
Stock Awards$3,287,387
Other$4,689
Total$4,168,001

Tovey received $3.3M in stock awards, accounting for 79% of the total pay in 2021.

Tovey also received $297.6K in bonus, $211.8K in non-equity incentive plan, $366.6K in salary and $4.7K in other compensation.

Rankings

In 2021, Chris Tovey's compensation ranked 3,204th out of 12,406 executives tracked by ExecPay. In other words, Tovey earned more than 74.2% of executives.

ClassificationRankingPercentile
All
3,204
out of 12,406
74th
Division
Manufacturing
1,296
out of 5,492
76th
Major group
Chemicals And Allied Products
528
out of 2,368
78th
Industry group
Drugs
469
out of 2,089
78th
Industry
Pharmaceutical Preparations
323
out of 1,536
79th

Pay ratio

Chris Tovey's Pay$4,168,001
Median Employee's Pay$212,134
Pay Ratio

20

to 1

In 2021, the annual total compensation of Chris Tovey was $4,168,001.

The annual total compensation of the median employee at Jazz Pharmaceuticals was $212,134.

The ratio of Chris Tovey's pay to the pay of median employee was therefore 20 to one.

Source: SEC filing on June 10, 2022.

Tovey's colleagues

We found four more compensation records of executives who worked with Chris Tovey at Jazz Pharmaceuticals in 2021.

2021

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2021

Daniel Swisher

Jazz Pharmaceuticals

President

2021

Renée Gal

Jazz Pharmaceuticals

Chief Financial Officer

2021

Robert MSCE

Jazz Pharmaceuticals

Executive Vice President, Global Head of Research and Development

News

You may also like